Ep. 238 - Biosecure Act: The Impact & What's Ahead
BioCentury This Week
00:00
The Biosecure Act and National Defense Authorization Act
Discussion on the exclusion of the Biosecure Act from the NDAA, bipartisan support in Congress, potential attachment to a must-pass bill, prohibition on federal government procurement from certain companies like WUSHI Aptech and BGI, implications on government programs, and strategies for companies to navigate the law's restrictions amid US-China tensions.
Transcript
Play full episode
